Orthopedics reimbursement alerts

This final LCD from WPS (J5/J8) establishes coverage criteria for Total Joint Arthroplasty across six Midwestern states, effective August 27, 2026. It governs both Part A and Part B billing, meaning i

This active Final LCD from WPS (J5/J8) establishes coverage criteria for Percutaneous Vertebral Augmentation (PVA) procedures—including vertebroplasty and kyphoplasty—for vertebral compression fractur

This active final LCD from Wellpoint Federal governs coverage of amniotic and placental-derived product injections and/or applications for non-wound musculoskeletal indications, effective April 1, 202

This active final LCD (L36406) from Wellpoint Federal governs Medicare coverage for minimally-invasive surgical fusion of the sacroiliac joint, effective April 1, 2026. It establishes specific coverag

This active Final LCD from Wellpoint Federal governs coverage criteria for Total Joint Arthroplasty under both Part A and Part B, effective April 1, 2026. It establishes the medical necessity, documen

This final LCD from Palmetto GBA restricts coverage of amniotic and placental-derived product injections and applications for non-wound musculoskeletal indications, effective July 16, 2026. It establi

The proposed Local Coverage Determination (LCD) for Knee Orthoses may have significant implications on billing for orthopedic practices. If implemented, providers may need to adjust their claims submi

The proposed LCD for Total Joint Arthroplasty may impact the coverage and reimbursement rates for providers performing this procedure. Ensuring compliance with new guidelines and requisite documentati

The implementation of the LCD for Platelet Rich Plasma (PRP) by Novitas may impact billing practices for providers offering this treatment. Facilities and providers need to ensure compliance with the

The introduction of the LCD for Platelet Rich Plasma by First Coast may significantly affect billing practices for providers utilizing this treatment. Understanding the effective date and coverage spe

The new Local Coverage Determination (LCD) for cervical fusion by NGS may affect billing practices significantly, as it will update the coding and documentation requirements starting January 30, 2025.

The new LCD regarding Routine Foot Care and Debridement of Nails may result in changes to reimbursement practices for podiatric services. Podiatrists should familiarize themselves with the updated gui

The introduction of the new LCD for Cervical Fusion by Noridian could significantly impact billing practices for related procedures. Providers should ensure that their documentation aligns with the up

The new LCD on Intervertebral Disc Repair establishes specific criteria for reimbursement, which could significantly affect the billing processes for spinal procedures. Providers will need to ensure c

The upcoming LCD on injections for tendon and ligament conditions may significantly impact reimbursement rates and coding practices for healthcare providers. It will be crucial for practices to align

The new Local Coverage Determination (LCD) from Noridian regarding Platelet Rich Plasma (PRP) injections could significantly impact billing practices as it outlines specific criteria for coverage. Pro

The implementation of the LCD on injections for tendon, ligament, ganglion cyst, tunnel syndromes, and Morton's neuroma may lead to increased scrutiny on existing claims. Providers must ensure their d

The new LCD for Intervertebral Disc Repair by Noridian will impact billing practices starting April 13, 2025. Providers should familiarize themselves with the specific criteria for coverage to ensure

The new LCD on Cervical Fusion by Noridian is expected to impact billing by clarifying the criteria for coverage, which may lead to changes in reimbursement rates. Providers should ensure that their d

The introduction of coverage for minimally invasive arthrodesis of the sacroiliac joint by Noridian may enhance compliance updates, particularly for orthopedic practices. Effective from October 23,

The introduction of the LCD for Minimally Invasive Arthrodesis of the Sacroiliac Joint may result in an increase in claims submissions for this procedure, thereby impacting overall billing patterns. I

The introduction of the LCD for amniotic and placental-derived product injections could significantly impact billing for musculoskeletal treatments. Providers will need to familiarize themselves with

The update on total hip arthroplasty will likely have billing implications that reflect new guidelines and coding requirements. Providers should familiarize themselves with revisions to ensure complia

The new Local Coverage Determination (LCD) for Total Knee Arthroplasty by Noridian may impact billing practices significantly. Providers should prepare for potential changes in approval processes and

The LCD for Percutaneous Vertebral Augmentation requires billing team review. This could lead to i

The LCD for Total Knee Arthroplasty by Noridian could significantly impact billing practices related to knee replacement surgeries. Providers should ensure documentation aligns with the specific crite

The LCD for Total Hip Arthroplasty under Noridian may require careful documentation to ensure appropriate reimbursement. Billing for this procedure will depend on adherence to the outlined criteria wh

The recent LCD for Percutaneous Vertebral Augmentation (PVA) will impact billing practices for osteoporotic vertebral compression fractures starting from its effective date. Providers must ensure prop

The issuance of the new LCD for Percutaneous Vertebral Augmentation (PVA) by Noridian is expected to significantly impact billing practices for osteoporotic vertebral compression fractures. Providers

The new LCD for Percutaneous Vertebral Augmentation (PVA) will impact how facilities bill for procedures related to Vertebral Compression Fracture (VCF). With new guidelines in place effective from No

The new LCD for Percutaneous Vertebral Augmentation (PVA) is set to impact reimbursement for vertebral compression fractures starting 11/20/2025. Providers should prepare for potential changes in cove

The new Local Coverage Determination (LCD) effective from January 29, 2026, for wound application of Cellular and/or Tissue Based Products (CTPs) for lower extremities indicates that specific billing

The implementation of the LCD for Total Joint Arthroplasty by CGS may lead to a shift in reimbursement strategies, potentially affecting billing for these procedures. Providers should prepare for upda

This LCD covers cervical fusion procedures, detailing the criteria for Medicare coverage and billing requirements. Services affected include those related to the surgical fusion of cervical vertebrae.